Salicylic acid

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available text.

Uses and Indications

This drug is indicated for the removal of corns, calluses, plantar warts, flat warts, and common warts that are less than 5 mm in size.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. It is recommended to soak the wart in warm water for approximately 5 minutes to facilitate the removal process. After soaking, the area must be dried completely.

Using the provided applicator, which may be a brush or cotton swab, one drop of the medication should be applied at a time to ensure that each wart is sufficiently covered. It is important to allow the medication to fully absorb and dry after application.

This procedure may be repeated once or twice daily as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Application is not recommended on irritated skin or any area that is infected or reddened, as this may exacerbate the condition. The product should not be applied to moles, birthmarks, warts with hair growing from them, or warts located on the face or mucous membranes due to the potential for adverse reactions. Additionally, individuals with diabetes or poor blood circulation should avoid use, as these conditions may increase the risk of complications. Finally, the product is contraindicated in patients with known allergies to any of its ingredients, as this could lead to severe allergic reactions.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

It is imperative to keep this product out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought by contacting a Poison Control Center at 1-800-222-1222.

Healthcare professionals should advise patients to discontinue use and consult a physician under the following circumstances: if the patient becomes pregnant or is planning to become pregnant while using the product, or if any discomfort persists. Monitoring for these conditions is essential to ensure patient safety and appropriate management.

Side Effects

Patients should be aware of the following warnings associated with the use of this product. It is intended for external use only and is flammable; therefore, it should be kept away from fire or flame. Additionally, it is crucial to keep the product out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact a Poison Control Center at 1-800-222-1222.

Patients are advised to discontinue use and consult a healthcare professional if they become pregnant or are planning to become pregnant while using the product. Furthermore, if discomfort persists, it is recommended to stop use and seek medical advice.

Drug Interactions

There are no specific drug interactions reported for this medication. Additionally, no laboratory test interactions have been identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Corn Remover Liquid. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients or those planning to become pregnant while using this product should discontinue use and consult a healthcare professional. The potential risks associated with the use of this product during pregnancy have not been fully established, and it is important for women of childbearing potential to discuss their treatment options with their healthcare provider to ensure the safety of both the mother and the developing fetus.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

If pregnancy occurs or is planned during the use of the product, it is advised to discontinue use and consult a healthcare professional. There is no relevant information available regarding non-teratogenic effects. Additionally, no pertinent data has been provided concerning nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately at 1-800-222-1222.

Patients should be instructed to discontinue use and consult a doctor if they become pregnant or are planning to become pregnant while using the product. Additionally, if discomfort persists, they should seek medical advice.

While using the product, patients should be cautioned to avoid contact with the eyes. In case of contact, they should flush the eye with water for 15 minutes. It is also important to advise patients to avoid inhaling vapors and to ensure that the bottle is capped tightly when not in use. Furthermore, patients should be informed to store the product out of direct sunlight and at room temperature, away from heat sources.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product at a temperature range of 20° to 25° C (68° to 77° F) to ensure its stability and efficacy. Additionally, the container must be kept tightly closed to protect the contents from contamination and maintain product integrity. Proper adherence to these storage conditions is crucial for optimal performance.

Additional Clinical Information

The medication is administered topically, with the recommended frequency being once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Wart Corn Remover Liquid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)